quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 1, 2026

NVIDIA and Microsoft Reinvent Windows PCs for the Age of Personal AI

View original at finance.yahoo.com
NVIDIA and Microsoft Reinvent Windows PCs for the Age of Personal AI NVIDIA RTX Spark — a 1-Petaflop Superchip, the Full CUDA and RTX Ecosystem, and Windows-Native Agents — a New Beginning for Personal Computers NVIDIA RTX SparkNVIDIA RTX Spark powers the world’s first Windows PCs purpose-built for personal agents, fea…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • MediaTek's collaboration with NVIDIA contributed to best-in-class power efficiency, performance and connectivity for the RTX Spark Grace CPU

    60% confidence

  • RTX Spark delivers 1 petaflop of AI performance with industry-leading power efficiency and up to 128GB of unified memory

    60% confidence

  • RTX Spark can run 120B-parameter LLMs with up to 1 million tokens context using local agents

    60% confidence

  • The PC is being reinvented. For forty years, you launched apps. With RTX Spark and Microsoft Windows, you ask — and the PC does the work. This is the new PC. The personal AI computer.

    60% confidence

  • RTX Spark enables rendering ultralarge 90GB+ 3D scenes, editing 12K 4:2:2 video, generating 4K AI videos, and playing AAA games at 1440p and over 100 frames per second

    60% confidence

  • Adobe's rearchitected Photoshop and Premiere deliver 2x faster AI and graphics performance on RTX Spark

    60% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com